Skip to content
OpenCapital
Get started

Lantronix LTRX Concentration Risk %

Concentration Risk % at other companies

Gyre Therapeutics, Inc. logo
Gyre Therapeutics, Inc.GYRE
93.1%-5.3pp
Heartland Express logo
Heartland ExpressHTLD
32%+6.0pp
Enovix Corporation logo
Enovix CorporationENVX
83%+36.0pp
RF Industries logo
RF IndustriesRFIL
100%0.0pp
Weis Markets logo
Weis MarketsWMK
100%0.0pp
Lantronix logo
LantronixLTRX
92%-2.0pp

Other financials

Income statement

See full
Revenue$30.2M+5.9%
Gross profit$13.0M+4.9%
Operating income-$1.1M+68.5%
Net income-$1.2M+69.5%
EPS (diluted)-$0.03+70.0%

Balance sheet

See full
Cash & equivalents$23.5M+17.6%
Total debt$8.7M-30.6%
Total equity$74.5M-1.3%
Total assets$120.0M-3.4%

Cash flow

See full
Operating cash flow$2.2M-32.9%
CapEx$237.0K+95.9%
Free cash flow$1.9M-37.9%

Valuation

See full
Market cap$262.3M+134%
Enterprise value$247.47M+139%
P/S2.2×+1.3×

Profitability

See full
Gross margin42.9%+1.8pp
Operating margin-5.8%—
Net margin-5.5%-0.5pp
FCF margin7.1%+1.5pp

Returns & leverage

See full
Return on equity-8.7%-1.7pp
Debt / equity0.1×0.0×
Current ratio2.7×+0.1×